Iovance Biotherapeutics

Manufacturing · California, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

825 Industrial Rd Ste 400, San Carlos, C...

Phone Number

(650) 260-7120

Revenue

$325 Million

Stock Symbol

IOVA

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Iovance Biotherapeutics

Iovance Biotherapeutics, founded in 2007 and headquartered in San Carlos, California, is a biopharmaceutical company developing tumor-infiltrating lymphocyte therapies against cancer.Explore more
Iovance Biotherapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: IOVAShow more

Iovance Biotherapeutics Org Chart

FV
United States flag for contact location.

Interim Chief Executive Officer & General Cou...

PhoneEmail
Igor Bilinsky, Chief Operating Officer at Iovance Biotherapeutics
United States flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SM
United States flag for contact location.

Global Senior VP, Supply Chain & Logistics

PhoneEmail
ML
United States flag for contact location.

Vice President, Drug Safety

PhoneEmail
AK
United States flag for contact location.

Vice President, Quality Control

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Iovance Biotherapeutics

Compare insights from companies similar to Iovance Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Iovance Biotherapeutics

$325M
501-1,000
Public
$1.1B
2007
FV
Frederick G. VogtInterim CEO & General Counsel
$580M
1K - 5K
Public
$3B
2015
TT
Thomas TrimarchiPresident & Chief Financial Officer
$117M
501-1,000
Public
$250M
2015
JJ
Juan JaenPresident & Co-Founder & Board of Directors
$101.2M
201-500
Public
$526M
2015
PE
Pamela EspositoChief Business Officer
$39.2M
1K - 5K
Private
-
1984
$28.3M
201-500
Private
-
-
CA
Curtis AndrewsExecutive VP, Sales & Marketing
<$5M
501-1,000
Public
$1.3B
2015
KT
Karen TynanOwner & CEO
Illustration of an envelope

Iovance Biotherapeutics Tech Stack

A closer look at the technologies used by Iovance Biotherapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Iovance Biotherapeutics

What is Iovance Biotherapeutics's stock symbol?
Iovance Biotherapeutics's stock symbol is IOVA
What is Iovance Biotherapeutics's official website?
Iovance Biotherapeutics's official website is www.iovance.com
What is Iovance Biotherapeutics's Revenue?
Iovance Biotherapeutics's revenue is $325 Million
What is Iovance Biotherapeutics's SIC code?
Iovance Biotherapeutics's SIC: 28,283
What is Iovance Biotherapeutics's NAICS code?
Iovance Biotherapeutics's NAICS: 32,325
How many employees does Iovance Biotherapeutics have?
Iovance Biotherapeutics has 501-1,000 employees
What industry does Iovance Biotherapeutics belong to?
Iovance Biotherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Iovance Biotherapeutics competition?
Iovance Biotherapeutics top competitors include: Replimune, Therakos, BridgeBio Pharma, Arcus Biosciences
What technology does Iovance Biotherapeutics use?
Some of the popular technologies that Iovance Biotherapeutics uses are: Freshservice, Zingfit, DocuSign, WordPress.org
How do I contact Iovance Biotherapeutics?
Iovance Biotherapeutics contact info: Phone number: (650) 260-7120 Website: www.iovance.com
What does Iovance Biotherapeutics do?

Iovance Biotherapeutics, founded in 2007 and headquartered in San Carlos, California, is a biopharmaceutical company developing tumor-infiltrating lymphocyte therapies against cancer.... Read More

What are Iovance Biotherapeutics social media links?
Iovance Biotherapeutics Linkedin page Iovance Biotherapeutics Twitter page
Who invested in Iovance Biotherapeutics?
Iovance Biotherapeutics has 12 investors including Broadfin Capital, Perceptive Advisors, venBio Select Advisor and Three Arch Opportunity Fund.
Is Iovance Biotherapeutics a public company?
Yes, Iovance Biotherapeutics is a public company and is traded under the symbol IOVA
See more information about Iovance Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.